VANCOUVER, British Columbia, March 22, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Tuesday, March 27, 2012 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to provide a corporate update and reports its 2011 audited operating results.
